The analysis project was launched in 2016 in order to raise the investors' level of knowledge of about TASE listed technology and biomed companies and the markets in which the companies operate, thus creating appropriate pricing and increasing the exposure of investors from Israel and abroad. Its goal is to encourage investments in these companies by removing the barrier of lacking understanding in the market.
In order to maintain professional, independent and unbiased analysis, the companies signed an agreement with the TASE to receive the analysis services for an obligatory period of two years. The companies cannot withdraw from the project during this period. The analysis is funded by the companies surveyed with funding from the Chief Scientist and the TASE.
The Tel-Aviv Stock Exchange (TASE) and Frost & Sullivan have signed in 2019 an agreement for the analysis of technology and biomed companies listed on TASE.
The analyses will be published, at least four times a year, following the publication of the companies' financial statements. In addition, updates will be published upon the occurrence of a significant event in a company that requires updating in the latest analytical work. The English analyses are published by the research companies worldwide, through the main information distributors, and large distribution channels.
Frost & Sullivan
A leading global consulting, and market & technology research firm that employs a staff of 1,800, which includes analysts, experts, and growth strategy consultants at approximately 50 branches across 6 continents, including in Herzliya Pituach, Israel. Frost & Sullivan will utilize the experience and know-how accumulated over the course of 55 years in medical technologies, life sciences, technology, energy, and other industrial fields, including the publication of tens of thousands of market and technology research reports, and economic analyses and valuations. For additional information on Frost & Sullivan's capabilities, visit: www.frost.com.
View all the analyses published in the framework of the project:
Frost & Sullivan: https://ww2.frost.com/research/equity-research/